Association of Antenatal Corticosteroids and Magnesium Sulfate Therapy With Neurodevelopmental Outcome in Extremely Preterm Children

被引:22
|
作者
Gentle, Samuel J.
Carlo, Waldemar A.
Tan, Sylvia
Gargano, Marissa
Ambalavanan, Namasivayam
Chawla, Sanjay
Bell, Edward F.
Bann, Carla M.
Hintz, Susan R.
Heyne, Roy J.
Tita, Alan
Higgins, Rosemary D.
机构
[1] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA
[2] RTI Int, Stat & Epidemiol Unit, Res Triangle Pk, NC USA
[3] Wayne State Univ, Childrens Hosp Michigan, Dept Pediat, Detroit, MI USA
[4] Wayne State Univ, Hutzel Womens Hosp, Detroit, MI USA
[5] Univ Iowa, Dept Pediat, Iowa City, IA 52242 USA
[6] Stanford Univ, Sch Med, Dept Pediat, Palo Alto, CA 94304 USA
[7] UT Southwestern, Dept Pediat, Dallas, TX USA
[8] Univ Alabama Birmingham, Dept Obstet & Gynecol, Birmingham, AL 35294 USA
[9] Univ Alabama Birmingham, Ctr Womens Reprod Hlth, Birmingham, AL USA
[10] George Mason Univ, Dept Global & Community Hlth, Fairfax, VA 22030 USA
[11] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Rockville, MD USA
来源
OBSTETRICS AND GYNECOLOGY | 2020年 / 135卷 / 06期
基金
美国国家卫生研究院;
关键词
NECROTIZING ENTEROCOLITIS; INFANTS BORN; EXPOSURE; NEUROPROTECTION; BIRTH; MORTALITY;
D O I
10.1097/AOG.0000000000003882
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To test the primary hypothesis that extremely preterm children antenatally exposed to both magnesium sulfate and antenatal corticosteroids have a lower rate of severe neurodevelopmental impairment or death compared with those exposed to antenatal corticosteroids alone. METHODS: This was a prospective observational study of children born at 22 0/7-26 6/7 weeks of gestation from 2011 to 2014 atEunice Kennedy ShriverNational Institute of Child Health and Human Development Neonatal Research Network hospitals (N=3,093). The primary outcome was severe neurodevelopmental impairment or death at 18-26 months of corrected age follow-up based on exposure to antenatal corticosteroids and magnesium sulfate or antenatal corticosteroids alone. Secondary outcomes included components of severe neurodevelopmental impairment by exposure group and comparisons of severe neurodevelopmental impairment or death between children exposed to both antenatal corticosteroids and magnesium sulfate with those exposed to magnesium sulfate alone or to neither antenatal corticosteroids nor magnesium sulfate. Logistic regression models adjusted for background characteristics. RESULTS: Children exposed to both antenatal corticosteroids and magnesium sulfate had a lower rate of severe neurodevelopmental impairment or death (813/2,239, 36.3%) compared with those exposed to antenatal corticosteroids alone (225/508, 44.3%; adjusted odds ratio [aOR] 0.73; 95% CI 0.58-0.91), magnesium sulfate alone (47/89, 53%; aOR 0.49; 95% CI 0.29-0.82), or neither therapy (121/251; 48.2%; aOR 0.66, 95% CI 0.49-0.89). Similarly, children exposed to both antenatal corticosteroids and magnesium sulfate had a lower rate of death compared with either or neither therapy, but the rate of severe neurodevelopmental impairment among survivors did not differ between exposure groups. CONCLUSION: In children born between 22 0/7 and 26 6/7 weeks of gestation, exposure to both antenatal corticosteroids and magnesium sulfate was associated with lower rates of severe neurodevelopmental impairment or death and death compared with exposure to antenatal corticosteroids alone.
引用
收藏
页码:1377 / 1386
页数:10
相关论文
共 50 条
  • [1] Antenatal magnesium sulfate and neurodevelopmental outcome of preterm infants born to preeclamptic mothers
    Bozkurt, Ozlem
    Eras, Zeynep
    Canpolat, Fuat Emre
    Oguz, Serife Suna
    Uras, Nurdan
    Dilmen, Ugur
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2016, 29 (07): : 1101 - 1104
  • [2] Association of Antenatal Corticosteroids With Mortality, Morbidity, and Neurodevelopmental Outcomes in Extremely Preterm Multiple Gestation Infants
    Boghossian, Nansi S.
    McDonald, Scott A.
    Bell, Edward F.
    Carlo, Waldemar A.
    Brumbaugh, Jane E.
    Stoll, Barbara J.
    Laptook, Abbot R.
    Shankaran, Seetha
    Walsh, Michele C.
    Das, Abhik
    Higgins, Rosemary D.
    JAMA PEDIATRICS, 2016, 170 (06) : 593 - 601
  • [3] Antenatal Magnesium Sulfate and Neurologic Outcome in Preterm Infants
    Doyle, Lex W.
    Crowther, Caroline A.
    Middleton, Philippa
    Marret, Stephane
    OBSTETRICS AND GYNECOLOGY, 2009, 113 (06): : 1327 - 1333
  • [4] Neurodevelopmental outcome descriptions in cohorts of extremely preterm children
    Ding, Sharon
    Mew, Emma J.
    Chee-A-Tow, Alyssandra
    Offringa, Martin
    Butcher, Nancy J.
    Moore, Gregory P.
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2020, 105 (05): : 510 - 519
  • [5] Antenatal Corticosteroids and Magnesium Sulfate for Improved Preterm Neonatal Outcomes: A Review of Guidelines
    Tsakiridis, Ioannis
    Mamopoulos, Apostolos
    Athanasiadis, Apostolos
    Dagklis, Themistoklis
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2020, 75 (05) : 299 - 307
  • [6] Antenatal magnesium sulfate is beneficial or harmful in very preterm and extremely preterm neonates: a new insight
    Garg, Bhawan Deep
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2019, 32 (12): : 2084 - 2090
  • [7] Neurodevelopmental Outcomes After Late Preterm Antenatal Corticosteroids
    Gyamfi-Bannerman, Cynthia
    Clifton, Rebecca G.
    Tita, Alan T. N.
    Blackwell, Sean C.
    Longo, Monica
    de Voest, Jessica A.
    O'Shea, T. Michael
    Bousleiman, Sabine Z.
    Ortiz, Felecia
    Rouse, Dwight J.
    Metz, Torri D.
    Saade, George R.
    Rood, Kara M.
    Heyborne, Kent D.
    Thorp, John M., Jr.
    Swamy, Geeta K.
    Grobman, William A.
    Gibson, Kelly S.
    El-Sayed, Yasser Y.
    Macones, George A.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2024, 331 (19): : 1629 - 1637
  • [8] Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births
    Aviram, Amir
    Murphy, Kellie
    McDonald, Sarah
    Asztalos, Elizabeth
    Zaltz, Arthur
    Redelmeier, Donald
    Shah, Baiju
    Barrett, Jon
    Melamed, Nir
    ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 2022, 107 (03): : 250 - 255
  • [9] Antenatal magnesium sulfate and the postnatal response of the ductus arteriosus to indomethacin in extremely preterm neonates
    Y Katayama
    H Minami
    M Enomoto
    T Takano
    S Hayashi
    Y K Lee
    Journal of Perinatology, 2011, 31 : 21 - 24
  • [10] Antenatal magnesium sulfate and intestinal morbidities in preterm infants with extremely low gestational age
    Kim, Seh Hyun
    Kim, Yoo-Jin
    Shin, Seung Hyun
    Cho, Hannah
    Shin, Seung Han
    Kim, Ee-Kyung
    Kim, Han-Suk
    Hong, Subeen
    Lee, Seung Mi
    PEDIATRICS AND NEONATOLOGY, 2021, 62 (02): : 202 - 207